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Recently discovered respiratory viruses were detected 
in 19 (9.2%) of 205 nasal swab specimens from children in 
Brazil with respiratory illnesses. Five each were positive for 
human metapneumovirus (HMPV) alone and human bocav-
irus (HBoV) alone, 3 for human coronaviruses (HCoV-HKU1 
or -NL63) alone, and 6 for more than 1 recently discovered 
virus.
V
iral infections are among the leading causes of respira-
tory disease in children. Most of these infections are 
caused by respiratory syncytial virus (RSV), inﬂ  uenza vi-
rus A or B (FluV), parainﬂ  uenza virus (PIV), rhinovirus 
(RV), or adenovirus (AdV). Several recently discovered 
viruses, such as human metapneumovirus (HMPV), human 
bocavirus (HBoV), and the human coronaviruses (HCoVs) 
NL63 and HKU1, have been identiﬁ  ed as potential respira-
tory pathogens (1). In addition, 2 new human polyomavi-
ruses (HPyVs), KIPyV and WUPyV, have been detected 
in patients with respiratory infections (1). In Brazil, epide-
miologic studies have demonstrated the extent to which vi-
ruses cause respiratory illness in children (2–4). However, 
because such studies have focused on the most common 
viral pathogens, the extent to which the novel respiratory 
viruses are etiologic agents of respiratory disease in Bra-
zilian children remains unknown. In this study, we sought 
to investigate the occurrence of respiratory infections as-
sociated with HMPV, HBoV, HCoV-HKU1, HCoV-NL63, 
KIPyV, and WUPyV among children in Brazil.
The Study
The study protocol was reviewed and approved by the 
research ethics committees of the Institute of Puericulture 
and Pediatrics Martagão Gesteira of the Federal University 
of Rio de Janeiro and the Educational Foundation of Serra 
dos Órgãos of Teresópolis. The parents of all children in-
volved in the study gave informed consent for their chil-
dren’s participation in accordance with Resolution 196/96 
of the Brazilian Ministry of Health.
Nasal swabs from 205 children (median age 3.3 years; 
range 1 month to 15 years) with acute upper or lower respi-
ratory illnesses were collected from March 2006 through 
October 2007 and tested for viral pathogens. Acute respi-
ratory illness was deﬁ  ned by the presence of rhinorrhea, 
cough, respiratory distress, or sore throat, associated or not 
with fever, for a maximum duration of 7 days. The speci-
mens were collected from hospitalized patients, emergency 
departments, and walk-in clinics at 2 university hospitals in 
the cities of Rio de Janeiro and Teresópolis. Relevant clini-
cal information, including patients’ hospitalization status, 
age, sex, and clinical symptoms, was collected during the 
ﬁ  rst medical visit by means of a standard questionnaire.
The nasal swabs were immersed in 1 mL of virus 
transport media and kept at –70oC until processing. Nucleic 
acid was extracted from 200 μL of the sample by using the 
Wizard Genomic DNA Puriﬁ  cation kit (Promega, Madi-
son, WI, USA) or RNAgents kit (Promega) according to 
the manufacturer’s instructions. Specimens were tested 
for presence of FluV A and B (5), PIV 1- 4 (6), AdV (7), 
RSV (8), RV (8), HMPV (9), HBoV (10), WUPyV (11), 
and KIPyV (12) by conventional PCR assays as previously 
described. A real-time PCR protocol was used for detection 
of HCoVs (229E, OC43, NL63, and HKU1) (13).
Of the 205 samples tested, 63 (30.7%) were posi-
tive for at least 1 of the viral pathogens speciﬁ  ed above. 
Nineteen (9.2%) were positive for at least 1 of the newly 
described viruses: 5 for HMPV only, 5 for HBoV only, 3 
for HCoV-HKU1 or HCoV-NL63 only, and 6 for co-infec-
tions with these viruses, including 2 samples positive for 
KIPyV or WUPyV. Of the samples positive for common 
respiratory viruses, 33 were positive for rhinovirus only, 
5 for FluV A only, 3 for RSV only, and 1 each for HCoV-
OC43 and AdV only. Two samples were positive for >1 
common respiratory viruses, and PIV was not detected (on-
line Appendix Table, available from  www.cdc.gov/EID/
content/15/5/806-appT.htm). The age of the patients infect-
ed with the newly described viruses ranged from 4 months 
to 11 years (median 2.7 years). The most frequent clini-
cal symptoms were fever, rhinorrhea, cough, sore throat, 
wheezing, bronchiolitis, and pneumonia (Table). Although 
the specimens were collected from symptomatic children 
and a wide range of viruses were screened for by highly 
sensitive methods, less than one third of the samples were 
positive. Perhaps if we had collected nasopharyngeal swabs 
or aspirates, the percentage of samples that tested positive 
would have been higher.
The diagnosis for most patients infected with HCoV-
NL63 or HCoV-HKU1 was pneumonia. Of the 3 patients 
with single infections, 2 were hospitalized and 1 was treat-
ed at the emergency department; the 2 patients with mixed 
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infection of HCoV-NL63 and HMPV or RV were treated 
at walk-in clinics.
Patients with HMPV infections had a myriad of 
symptoms, including fever, cough, rhinorrhea, wheezing, 
and sore throat. Of the 5 patients with single infections, 
4 were treated at walk-in clinics and 1 was treated at an 
emergency department. A patient co-infected with HMPV 
and HCoV-NL63 was treated at a walk-in clinic, and a pa-
tient co-infected with HMPV and KIPyV and 1 co-infected 
with HMPV, HCoV-OC43, AdV, and RV were treated at 
an emergency department. The patient co-infected with 
KIPyV was a 4-year-old boy with cough, fever, rhinorrhea, 
and wheezing.
HBoV was detected in samples from 5 patients as a 
single infection and in samples from 2 patients as a co-in-
fection with RV or WUPyV. Three patients had pneumonia 
(2 single infections and 1 co-infection with RV). Two of 
the 3 were treated at walk-in clinics; 1 of the patients with 
only HBoV infection was hospitalized. The patient co-in-
fected with WUPyV was a 10-month-old boy who had been 
treated at an emergency department after exhibiting cough, 
rhinorrhea, and laryngomalacia.
Conclusions
Previous studies have documented the importance of 
respiratory virus infections among pediatric patients in 
Brazil (2–4). However, the effect of the so-called emerg-
ing respiratory viruses on the children of Brazil is yet to be 
clariﬁ  ed. Few studies have demonstrated the circulation of 
HMPV among Brazilian children (4,14), and to our knowl-
edge, none have described the circulation of HBoV, HCoV, 
or HPyVs as respiratory pathogens in Brazil, although 1 
study did report the presence of HBoV in the stools of Bra-
zilian children with gastroenteritis (15). Our ﬁ  nding that 
HMPV, HBoV, HCoV-HKU1 or HCoVB-NL63, or the 
newly described KIPyV or WUPyV was present in 9.2% 
of the tested samples suggests that these viruses could be 
important respiratory pathogens in the country. However, 
further investigative studies that include appropriately 
matched control groups will be necessary to demonstrate 
that these novel viruses act as etiologic agents of respira-
tory disease in Brazil.
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